Pharmaceuticals

AstraZeneca commits $15 billion investment in China through 2030 to expand R&D and manufacturing

Mubadala Bio expands women’s health portfolio with launch of new hormone therapy

GENNVAX breaks ground on $150 million vaccine plant set to be region’s largest

Freya Pharma Solutions rebrands as Arletta Pharma Solutions as company enters next stage of women’s healthcare development

Sofinnova Partners closes €650 million flagship fund as capital raised reaches €1.5bn in one year

Verastem Oncology sets price for $90 million Public Offering of shares and pre-funded warrants

Takeda signs $11 billion deal with China’s Innovent to expand cancer drug pipeline

City Bank and UNFPA Join Forces to Empower Girls and Women in Bangladesh

Breaking Pills and Barriers: Women leading the charge in pharma innovation

US FDA approves GSK’s ‘Blujepa’ for treating UTIs in women and girls